|

Clinical Trials in New Jersey

1,142 recruiting studies across 113 cities, spanning 17 conditions.

Browse by Condition

All Trials in New Jersey

Phase
Trial Phase Location
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPhase 1/2Basking Ridge
A Dietary Study for People With Multiple MyelomaN/ABasking Ridge
A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesN/ABasking Ridge
A Registry for People With Lung Cancer—Basking Ridge
A Registry for People With T-cell Lymphoma—Basking Ridge
A Study Collecting Health Information to Understand and Prevent Gastric Cancer—Basking Ridge
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)N/ABasking Ridge
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat CancerPhase 3Basking Ridge
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 3Basking Ridge
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular TumorsN/ABasking Ridge
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)N/ABasking Ridge
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free HomeN/ABasking Ridge
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their PainPhase 1Basking Ridge
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)Phase 1Basking Ridge
A Study of 177Lu-PSMA-617 in People With GliomasPhase 1Basking Ridge
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Phase 1Basking Ridge
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerPhase 2Basking Ridge
A Study of 2141-V11 in People With Esophageal, Gastric, or Gastroesophageal Junction AdenocarcinomaPhase 1/2Basking Ridge
A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast CancerPhase 1Basking Ridge
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerPhase 1Basking Ridge
A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaPhase 1Basking Ridge
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)Phase 2Basking Ridge
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1/2Basking Ridge
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerPhase 1Basking Ridge
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaPhase 2Basking Ridge
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)Phase 1Basking Ridge
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander PlacementPhase 4Basking Ridge
A Study of Armored CAR T Cells in People With CancerPhase 1Basking Ridge
A Study of Avutometinib and Defactinib in People With Thyroid CancerPhase 2Basking Ridge
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerPhase 2Basking Ridge
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)Phase 2Basking Ridge
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseasePhase 2Basking Ridge
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerPhase 1Basking Ridge
A Study of BV-AVD in People With Bulky Hodgkin LymphomaPhase 2Basking Ridge
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantPhase 2Basking Ridge
A Study of Blood Pressure Control During Cancer TreatmentPhase 2Basking Ridge
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyPhase 2Basking Ridge
A Study of Botensilimab and Balstilimab for Rectal AdenocarcinomaPhase 2Basking Ridge
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid LeukemiaPhase 1Basking Ridge
A Study of CRD3874-SI in People With LeukemiaPhase 1Basking Ridge
A Study of CRD3874-SI in People With Solid TumorsPhase 1Basking Ridge
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction CancerPhase 2Basking Ridge
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With CancerN/ABasking Ridge
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck CancerPhase 1Basking Ridge
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaPhase 2Basking Ridge
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)—Basking Ridge
A Study of Changes to Prostate ProceduresPhase 3Basking Ridge
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell LymphomaPhase 2Basking Ridge
A Study of Counseling Support for Cancer Survivors Age 65+N/ABasking Ridge
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)Phase 2Basking Ridge
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast CancerPhase 2Basking Ridge
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple MyelomaPhase 1/2Basking Ridge
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck CancerPhase 2Basking Ridge
A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisPhase 1Basking Ridge
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Phase 2Basking Ridge
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic CancerPhase 1Basking Ridge
A Study of Ear Nerve Stimulation to Treat Eye InflammationPhase 1Basking Ridge
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerPhase 2Basking Ridge
A Study of Elranatamab and Cyclophosphamide in People With Multiple MyelomaPhase 2Basking Ridge
A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaPhase 2Basking Ridge
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast CancerPhase 2Basking Ridge
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)Phase 1Basking Ridge
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)Phase 2Basking Ridge
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaPhase 2Basking Ridge
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell LymphomaPhase 2Basking Ridge
A Study of Herbal Supplements in Cancer Survivors With ConstipationN/ABasking Ridge
A Study of Hospital-at-Home for People Receiving TarlatamabN/ABasking Ridge
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors—Basking Ridge
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Phase 2Basking Ridge
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and ChestPhase 2Basking Ridge
A Study of Isoquercetin in People With Ovarian CancerPhase 2Basking Ridge
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerPhase 1/2Basking Ridge
A Study of Ivonescimab in People With Endometrial and Cervical CancersPhase 2Basking Ridge
A Study of Ivonescimab in People With LeiomyosarcomaPhase 2Basking Ridge
A Study of Ivonescimab in People With Non-Small Cell Lung CancerPhase 1/2Basking Ridge
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerPhase 1/2Basking Ridge
A Study of Language Interpretation Solutions for People With Breast CancerN/ABasking Ridge
A Study of Lower Dose Radiation Therapy for People With Prostate CancerPhase 2Basking Ridge
A Study of Lung Cancer Risk—Basking Ridge
A Study of Lung Cancer Screening in People With Unexplained Weight Loss—Basking Ridge
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)Phase 1Basking Ridge
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerPhase 1Basking Ridge
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening—Basking Ridge
A Study of Meaning-Centered Psychotherapy for Caregivers to People With CancerN/ABasking Ridge
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell TransplantPhase 2Basking Ridge
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal MesotheliomaPhase 1Basking Ridge
A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaPhase 1/2Basking Ridge
A Study of Mirdametinib in People With Central Nervous System TumorsPhase 1/2Basking Ridge
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Phase 2Basking Ridge
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaPhase 2Basking Ridge
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial CancerN/ABasking Ridge
A Study of Multiparametric Ultrasound Imaging MethodsN/ABasking Ridge
A Study of Music Therapy for Anxiety in People With CancerN/ABasking Ridge
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous LeukemiaPhase 1Basking Ridge
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy—Basking Ridge
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma—Basking Ridge
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic LeukemiaPhase 2Basking Ridge
A Study of Opportunistic Salpingectomy to Prevent Ovarian CancerN/ABasking Ridge
A Study of Pasireotide in People With ProlactinomaPhase 2Basking Ridge
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegPhase 2Basking Ridge
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerPhase 2Basking Ridge
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast CancerPhase 1Basking Ridge
A Study of Pembrolizumab in People With Ultra-Rare SarcomasPhase 2Basking Ridge
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell TransplantPhase 2Basking Ridge
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)Phase 2Basking Ridge
A Study of Questionnaires in Adolescents and Young Adults With Cancer—Basking Ridge
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell CarcinomaPhase 2Basking Ridge
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerPhase 2Basking Ridge
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueN/ABasking Ridge
A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasPhase 3Basking Ridge
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat CancerPhase 2Basking Ridge
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPhase 2Basking Ridge
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic ChangePhase 2Basking Ridge
A Study of Revaree Plus in People With Breast CancerPhase 4Basking Ridge
A Study of Revumenib and Mezigdomide in People With LeukemiaPhase 1/2Basking Ridge
A Study of Romosozumab in People With Breast Cancer and OsteoporosisPhase 2Basking Ridge
A Study of Ruxolitinib and Duvelisib in People With LymphomaPhase 1Basking Ridge
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantPhase 2Basking Ridge
A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerPhase 2Basking Ridge
A Study of SER-155 to Treat Diarrhea in People on ImmunotherapyPhase 1Basking Ridge
A Study of SX-682 in Combination With Proton Craniospinal Irradiation (pCSI) in People With Leptomeningeal DiseasePhase 1Basking Ridge
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Phase 2Basking Ridge
A Study of Sacituzumab Govitecan in People With MesotheliomaPhase 2Basking Ridge
A Study of Selinexor in People With Wilms Tumors and Other Solid TumorsPhase 2Basking Ridge
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial CancerEarly 1Basking Ridge
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPhase 2Basking Ridge
A Study of Skipping Radiation Therapy in People With Breast CancerN/ABasking Ridge
A Study of Sotorasib in People With Brain TumorsPhase 1Basking Ridge
A Study of Sotorasib in People With Non-Small Cell Lung CancerPhase 2Basking Ridge
A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic CancerPhase 2Basking Ridge
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainPhase 2Basking Ridge
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainPhase 2Basking Ridge
A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection SurgeryN/ABasking Ridge
A Study of Surgery and Radiotherapy in People With Breast CancerPhase 2Basking Ridge
A Study of Surgical Techniques During CystectomyPhase 3Basking Ridge
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyPhase 2Basking Ridge
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentPhase 2Basking Ridge
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)Phase 2Basking Ridge
A Study of Tarlatamab for People With Prostate CancerPhase 2Basking Ridge
A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaPhase 1Basking Ridge
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung CancerPhase 1Basking Ridge
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerPhase 1/2Basking Ridge
A Study of Treatment Delivery Preference In People With Kidney CancerPhase 4Basking Ridge
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerPhase 3Basking Ridge
A Study of Tucatinib and Trastuzumab in People With Rectal CancerPhase 2Basking Ridge
A Study of Valemetostat in Combination With Atezolizumab in People With Lung CancerPhase 1Basking Ridge
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)Phase 2Basking Ridge
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy—Basking Ridge
A Study of ZEN003694 in People With Squamous Cell Lung CancerPhase 2Basking Ridge
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.Phase 2Basking Ridge
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast CancerPhase 3Basking Ridge
A Study of a Decision Tool for People Considering Breast Reconstruction SurgeryN/ABasking Ridge
A Study of a New PET Scanner in People With Cancer—Basking Ridge
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With CancerN/ABasking Ridge
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)N/ABasking Ridge
A Study of a Side Effects and Resource Navigation Program for People With CancerN/ABasking Ridge
A Study of a Vaccine in Combination With Beta-glucan in People With NeuroblastomaPhase 2Basking Ridge
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerPhase 1Basking Ridge
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their CaregiversN/ABasking Ridge
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaPhase 2Basking Ridge
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerPhase 2Basking Ridge
A Study of the Use of 3D Technology to Guide Head and Neck SurgeryN/ABasking Ridge
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerPhase 2Basking Ridge
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)Phase 2Basking Ridge
A Study on the Effects of Exercise Therapy on Signs of Prostate CancerPhase 2Basking Ridge
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal CancersPhase 2Basking Ridge
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionPhase 3Basking Ridge
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerN/ABasking Ridge
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerPhase 3Basking Ridge
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantPhase 3Basking Ridge
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsPhase 3Basking Ridge
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerPhase 1Basking Ridge
A Study to Prevent and Improve Sexual Health Concerns for People With Breast CancerN/ABasking Ridge
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerN/ABasking Ridge
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationPhase 2Basking Ridge
Acupuncture for People Experiencing Period Loss Due to ChemotherapyPhase 2Basking Ridge
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryPhase 2Basking Ridge
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsN/ABasking Ridge
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders—Basking Ridge
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas—Basking Ridge
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPhase 2Basking Ridge
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer—Basking Ridge
Collecting Information About Treatment Results for Patients With Cushing's Syndrome—Basking Ridge
Collection of Information to Better Understand Young Onset Colorectal Cancer—Basking Ridge
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Phase 2Basking Ridge
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Phase 2Basking Ridge
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity CancerPhase 2/3Basking Ridge
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerPhase 3Basking Ridge
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With CancerN/ABasking Ridge
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Phase 3Basking Ridge
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer—Basking Ridge
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsPhase 2Basking Ridge
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer SurvivorsPhase 2Basking Ridge
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer—Basking Ridge
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor CancersPhase 1Basking Ridge
Factors Associated With Breast Cancer Risks and Outcomes—Basking Ridge
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) ProtocolPhase 4Basking Ridge
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryPhase 2Basking Ridge
Genomic Profiling in Cancer Patients—Basking Ridge
Germ Cell Tumor and Testicular Tumor DNA Registry—Basking Ridge
Glioma Developmental and HyperActive Ras Tumor (DHART) Board—Basking Ridge
Groningen International Study on Sentinel Nodes in Vulvar Cancer-IIIPhase 2Basking Ridge
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term RemissionPhase 2Basking Ridge
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms—Basking Ridge
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment—Basking Ridge
Impact of ICCAN on Cancer Treatment Completion and Quality of Life—Basking Ridge
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerPhase 3Basking Ridge
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseasePhase 2Basking Ridge
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaEarly 1Basking Ridge
Kidney Cancer DNA Registry—Basking Ridge
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma—Basking Ridge
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPhase 2/3Basking Ridge
Lymphedema Surveillance Study—Basking Ridge
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialN/ABasking Ridge
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Phase 2Basking Ridge
Malignant Polyp Registry—Basking Ridge
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasPhase 3Basking Ridge
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal CancerPhase 3Basking Ridge
Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot StudyN/ABasking Ridge
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma—Basking Ridge
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors—Basking Ridge
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease—Basking Ridge
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersPhase 2Basking Ridge
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3Basking Ridge
Pembrolizumab, Olaparib, and Temozolomide for People With GliomaPhase 2Basking Ridge
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaPhase 2Basking Ridge
Post-op T-DM1 in HER-2+ Salivary Gland CarcinomasPhase 2Basking Ridge
Radiation Therapy Approaches for People With Prostate CancerPhase 2Basking Ridge
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryPhase 2Basking Ridge
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology—Basking Ridge
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak—Basking Ridge
Researching the Effect of Exercise on CancerN/ABasking Ridge
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes—Basking Ridge
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations—Basking Ridge
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaN/ABasking Ridge
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard TreatmentPhase 1/2Basking Ridge
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerPhase 2Basking Ridge
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaPhase 1Basking Ridge
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryPhase 2Basking Ridge
Study of Aerobic Training for People Receiving Treatment for Breast CancerPhase 2Basking Ridge
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and HypogammaglobulinemiaPhase 2Basking Ridge
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsPhase 2Basking Ridge
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaPhase 2Basking Ridge
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPhase 2Basking Ridge
Study of a Support Program for Quality of Life in Chinese Cancer Patients and SurvivorsN/ABasking Ridge
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)Phase 3Basking Ridge
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial CancerPhase 1/2Basking Ridge
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerPhase 1/2Basking Ridge
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerPhase 2Basking Ridge
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobN/ABasking Ridge
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)Phase 2Basking Ridge
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerPhase 3Basking Ridge
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialPhase 3Basking Ridge
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyPhase 3Basking Ridge
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerPhase 3Basking Ridge
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)Phase 2Basking Ridge
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerPhase 3Basking Ridge
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialPhase 3Basking Ridge
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3Basking Ridge
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyPhase 3Basking Ridge
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell CarcinomaPhase 2Basking Ridge
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentPhase 3Basking Ridge
Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal CancerPhase 2Basking Ridge
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialPhase 3Basking Ridge
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell LymphomaPhase 2Basking Ridge
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerPhase 3Basking Ridge
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal CavityPhase 2/3Basking Ridge
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialPhase 2Basking Ridge
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur TrialPhase 2Basking Ridge
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerPhase 2Basking Ridge
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG TherapyPhase 3Basking Ridge
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)Phase 1Basking Ridge
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerPhase 3Basking Ridge
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerPhase 3Basking Ridge
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialPhase 2Basking Ridge
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesPhase 1Basking Ridge
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic LymphomaPhase 2Basking Ridge
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerPhase 1/2Basking Ridge
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPhase 2Basking Ridge
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyPhase 2/3Basking Ridge
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersPhase 2Basking Ridge
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPhase 4Basking Ridge
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Phase 3Basking Ridge
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemPhase 2Basking Ridge
Ulixertinib in People With Histiocytic NeoplasmsPhase 2Basking Ridge
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural MesotheliomaN/ABasking Ridge
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung CancerPhase 2Basking Ridge
Using Urine Samples to Identify Lung Cancer—Basking Ridge
Using a Blood Test and Software Tool to Guide Treatment for Venous ThromboembolismN/ABasking Ridge
Using an Artificial Intelligence (AI) Tool for Melanoma DiagnosisPhase 3Basking Ridge
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Phase 2Basking Ridge
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasPhase 2Basking Ridge
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland CancerN/ABasking Ridge
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerN/ABasking Ridge
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPhase 1/2Belleville
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyPhase 3Belleville
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)Phase 3Belleville
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Phase 3Belleville
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaPhase 3Belleville
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentPhase 4Belleville
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPhase 3Belleville
GEMINI-NSCLC: NSCLC Biomarker Study—Belleville
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7Phase 2/3Belleville
RADIANT: Pre-op Radiation With Abemaciclib and LetrozolePhase 1Belleville
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology—Belleville
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerPhase 3Belleville
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseasePhase 2/3Berkeley Heights
E-Mindfulness Approaches for Living After Breast CancerPhase 3Berkeley Heights
A Study of CX11 Tablets in Patients With Type 2 Diabetes MellitusPhase 2Berlin
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2Berlin
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)Phase 3Bloomfield
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaPhase 2/3Bloomfield
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLPhase 2Brick
Leveraging the Emergency Department (LEAD) StudyN/ABrick
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer—Brick
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC TrialPhase 3Brick
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—Bridgewater
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Bridgewater
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3Bridgewater
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Bridgewater
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3Bridgewater
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Bridgewater
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Bridgewater
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Bridgewater
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Bridgewater
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Bridgewater
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Bridgewater
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual DiseasePhase 3Bridgewater
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/ABrowns Mills
Alleviant ALLAY-HFrEF StudyN/ABrowns Mills
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Browns Mills
CCM OPEN HF Registry—Browns Mills
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/ABrowns Mills
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/ABrowns Mills
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCPhase 3Camden
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)Phase 3Camden
A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)Early 1Camden
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination TherapyPhase 3Camden
A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein ExpressionPhase 3Camden
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrencePhase 3Camden
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerPhase 2Camden
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabPhase 3Camden
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3Camden
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesPhase 1/2Camden
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial FibrillationPhase 2Camden
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerPhase 3Camden
Assessment of CCM in HF With Higher Ejection FractionN/ACamden
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerPhase 2Camden
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)Phase 2Camden
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/ACamden
Effects of Oncological Treatment During Pregnancy on Mother and Child—Camden
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Phase 3Camden
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialPhase 3Camden
Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation TherapyN/ACamden
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaPhase 3Camden
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes—Camden
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study—Camden
Nodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaPhase 2Camden
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPhase 4Camden
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabPhase 3Camden
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsPhase 3Camden
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerPhase 3Camden
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/ACamden
Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.Phase 2Camden
Prevail Global StudyN/ACamden
Product Surveillance Registry—Camden
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS BronchoscopyN/ACamden
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Phase 3Camden
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Phase 1/2Camden
SPYRAL GEMINI Pilot StudyN/ACamden
Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerPhase 3Camden
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Phase 3Camden
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabPhase 3Camden
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerN/ACamden
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Phase 3Camden
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/ACamden
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel SyndromeN/ACamden
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Phase 3Camden
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.Phase 3Camden
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPhase 3Camden
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade DysplasiaN/ACamden
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerPhase 2Camden
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Phase 3Camden
Transfusion Requirements in Younger Patients Undergoing Cardiac SurgeryN/ACamden
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPhase 3Camden
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerN/ACape May Court House
Focused Extracorporeal Shockwave Therapy for Knee ArthritisN/ACedar Knolls
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Phase 3Cherry Hill
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4Cherry Hill
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderPhase 2Cherry Hill
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety DisorderPhase 3Cherry Hill
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialPhase 2/3Cherry Hill
COPD Exacerbation Follow Up—Cherry Hill
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialPhase 3Cherry Hill
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolPhase 3Cherry Hill
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT TrialPhase 2Cherry Hill
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerPhase 3Cherry Hill
Multiple Sclerosis Implementation Network (Registry)—Cherry Hill
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerPhase 3Cherry Hill
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerPhase 3Cherry Hill
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialPhase 3Cherry Hill
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLLPhase 3Cherry Hill
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialPhase 3Cherry Hill
Time Restricted Eating for the Improvement of Outcomes in Patients With Stage I-III Breast Cancer Receiving Chemotherapy Before SurgeryN/ACherry Hill
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaPhase 3Cherry Hill
Persona Revision Knee System Outcomes—Chester
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaPhase 3Clark
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialN/AClifton
Shield Post-Approval Study Protocol—Clifton
A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaPhase 1East Brunswick
A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerPhase 1East Brunswick
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCPhase 1East Brunswick
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsPhase 1East Brunswick
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerPhase 2East Brunswick
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerPhase 2East Brunswick
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung CancerPhase 2East Brunswick
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerPhase 2East Brunswick
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid TumorsPhase 1/2East Brunswick
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaPhase 3East Brunswick
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)Phase 3East Brunswick
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerPhase 3East Brunswick
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerPhase 3East Brunswick
A Study in Patients With Metastatic Castration-Resistant Prostate CancerPhase 1East Brunswick
A Study of APG-3288 in Relapsed/Refractory Blood CancersPhase 1East Brunswick
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyPhase 3East Brunswick
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerPhase 3East Brunswick
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerPhase 1/2East Brunswick
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)Phase 1/2East Brunswick
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsPhase 1East Brunswick
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerPhase 3East Brunswick
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerPhase 1East Brunswick
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsPhase 1East Brunswick
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsPhase 1East Brunswick
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerPhase 3East Brunswick
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaPhase 3East Brunswick
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractPhase 3East Brunswick
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerPhase 3East Brunswick
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerPhase 2/3East Brunswick
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 2East Brunswick
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 3East Brunswick
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Phase 3East Brunswick
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPhase 3East Brunswick
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseasePhase 1East Brunswick
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsPhase 1East Brunswick
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)Phase 1/2East Brunswick
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseasePhase 3East Brunswick
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)Phase 3East Brunswick
Behavioral Exposure for Introceptive Tolerance RCTN/AEast Brunswick
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLPhase 2East Brunswick
DBC-664 in Adult Patients With Solid TumorsPhase 1East Brunswick
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)Phase 2East Brunswick
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsPhase 1East Brunswick
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCPhase 1/2East Brunswick
First-in-Human Study of DS-3939a in Participants With Advanced Solid TumorsPhase 1/2East Brunswick
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate CancerPhase 1/2East Brunswick
HMPL-A830 in Solid TumorsPhase 1/2East Brunswick
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsPhase 1East Brunswick
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPhase 2/3East Brunswick
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation—East Brunswick
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsPhase 1East Brunswick
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPhase 1/2East Brunswick
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-PositivePhase 2/3East Brunswick
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaPhase 2East Brunswick
SLV-154 Treatment of Advanced CancersPhase 1East Brunswick
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)Phase 2/3East Brunswick
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCPhase 3East Brunswick
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTPhase 3East Brunswick
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPhase 1/2East Brunswick
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Phase 2East Brunswick
Study of GS-2426 in Participants With Advanced Solid TumorsPhase 1East Brunswick
Study of Oral MRT-2359 With Apalutamide in Prostate CancerPhase 2East Brunswick
Study of SIR2501 in Solid Tumor Patients Receiving PaclitaxelPhase 2East Brunswick
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Phase 3East Brunswick
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian CancerPhase 1/2East Brunswick
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsPhase 1East Brunswick
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Phase 3East Brunswick
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerPhase 2East Brunswick
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsPhase 1/2East Brunswick
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerPhase 2East Brunswick
Visugromab in Cachexia International TrialPhase 2/3East Brunswick
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple SclerosisN/AEast Hanover
A Study Comparing Effectiveness of Kesimpta® (Ofatumumab) Versus Ocrevus® (Ocrelizumab) in Real-world Practice—East Hanover
A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer—East Hanover
A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan—East Hanover
A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients—East Hanover
Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support PersonsN/AEast Hanover
Pluvicto Real-world Investigation in Survival in Metastatic CRPC—East Hanover
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the CommunityN/AEast Hanover
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers—East Orange
ERP to Improve Functioning in Veterans With OCDN/AEast Orange
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 3East Orange
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 3Eatontown
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or OverweightPhase 3Eatontown
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Eatontown
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Eatontown
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Eatontown
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationPhase 3Edison
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Edison
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)N/AEdison
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid TumorsPhase 1/2Edison
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—Egg Harbor
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain MetastasesPhase 3Egg Harbor
ATATcH Alternating Treatment Plans for Advanced CancerPhase 2Elizabeth
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerPhase 3Elizabeth
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast CancerPhase 2Elizabeth
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerPhase 2Elizabeth
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedPhase 2Elizabeth
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerPhase 2Elizabeth
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Elmer
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Elmer
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPhase 1/2Englewood
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics—Englewood
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection—Englewood
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects—Englewood
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/AEnglewood
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentPhase 2Englewood
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyN/AEnglewood
One-Month DAPT in CABG PatientsPhase 3Englewood
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-—Englewood
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - MinoritiesPhase 3Englewood
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - WomenPhase 3Englewood
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)—Englewood
Tempus Small Cell Lung Cancer Observational Study (Sculptor)—Englewood
The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyPhase 3Englewood
Ultralow Dose PET Imaging for 18F-NaF UptakePhase 2Englewood
Ultralow Dose PET Imaging for PSMA ExpressionPhase 2Englewood
Ultralow Dose PET Imaging of 18F-FDG UptakePhase 2Englewood
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-FlutemetamolPhase 2Englewood
Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakePhase 2Englewood
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPhase 1/2Englewood
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/AFlemington
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 2Flemington
Molecular Genetics Studies of Cancer Patients and Their Relatives—Flemington
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Phase 3Flemington
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPhase 2Flemington
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3Flemington
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Phase 3Florham Park
A Study of DB-1310 in Advanced/Metastatic Solid TumorsPhase 1/2Florham Park
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesPhase 2Florham Park
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)Phase 3Florham Park
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHPhase 3Florham Park
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsN/AFlorham Park
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies—Florham Park
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerPhase 2Florham Park
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerPhase 3Florham Park
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)Phase 2Florham Park
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Phase 3Freehold
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerPhase 1/2Freehold
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)N/AFreehold
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/AFreehold
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) InterventionN/AGibbsboro
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Phase 3Hackensack
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Phase 3Hackensack
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)Phase 1/2Hackensack
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Phase 3Hackensack
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Phase 2Hackensack
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)Phase 1Hackensack
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Phase 3Hackensack
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Phase 3Hackensack
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)Phase 2/3Hackensack
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos StudyPhase 2Hackensack
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid TumorsPhase 1Hackensack
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin LymphomaPhase 1Hackensack
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS MutationsPhase 1/2Hackensack
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)Phase 1Hackensack
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid TumorsPhase 1/2Hackensack
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsPhase 1/2Hackensack
A Global Study of the PETAL Consortium—Hackensack
A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelPhase 4Hackensack
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2Hackensack
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Phase 2/3Hackensack
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)—Hackensack
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadPhase 1Hackensack
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsPhase 1Hackensack
A Phase 1 Study of LNCB74 in Advanced Solid TumorsPhase 1Hackensack
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid TumorsPhase 1Hackensack
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesPhase 1Hackensack
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)Phase 1/2Hackensack
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaPhase 1/2Hackensack
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaPhase 2Hackensack
A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsPhase 1Hackensack
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial TumorsPhase 2Hackensack
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—Hackensack
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Hackensack
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerPhase 3Hackensack
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPhase 1/2Hackensack
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsPhase 1Hackensack
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2Hackensack
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Phase 2Hackensack
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Phase 3Hackensack
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Phase 3Hackensack
A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsPhase 1Hackensack
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With EzabenlimabPhase 1Hackensack
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsPhase 1/2Hackensack
A Study of ASP3082 in Adults With Advanced Solid TumorsPhase 1Hackensack
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsPhase 1/2Hackensack
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesPhase 1/2Hackensack
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerPhase 2Hackensack
A Study of BG-C477 in Participants With Advanced Solid TumorsPhase 1Hackensack
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/2Hackensack
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/2Hackensack
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsPhase 1Hackensack
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)Phase 3Hackensack
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Phase 3Hackensack
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1Hackensack
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Phase 1Hackensack
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTPhase 2Hackensack
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Phase 1Hackensack
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionPhase 2Hackensack
A Study of LY4175408 in Participants With Advanced CancerPhase 1Hackensack
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2Hackensack
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)Phase 2Hackensack
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationPhase 3Hackensack
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPhase 1Hackensack
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)Phase 3Hackensack
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationPhase 1/2Hackensack
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Phase 3Hackensack
A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaPhase 2Hackensack
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsPhase 3Hackensack
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPhase 1/2Hackensack
A Study of ZL-1310 in Subjects With Small Cell Lung CancerPhase 1Hackensack
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1Hackensack
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTPhase 2Hackensack
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaPhase 1Hackensack
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Phase 2Hackensack
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2Hackensack
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsPhase 3Hackensack
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1/2Hackensack
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaPhase 3Hackensack
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationPhase 1Hackensack
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2Hackensack
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.Phase 1/2Hackensack
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple MyelomaPhase 1Hackensack
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPhase 3Hackensack
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Phase 3Hackensack
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsPhase 2Hackensack
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)Phase 1/2Hackensack
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Phase 1/2Hackensack
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/2Hackensack
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsPhase 1Hackensack
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1Hackensack
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsPhase 1/2Hackensack
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.Phase 1Hackensack
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsPhase 1Hackensack
A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid TumorsPhase 1/2Hackensack
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPhase 1/2Hackensack
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyPhase 3Hackensack
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLPhase 1Hackensack
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Phase 3Hackensack
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian CancersPhase 1Hackensack
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)Phase 1Hackensack
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor—Hackensack
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/2Hackensack
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)Phase 1/2Hackensack
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPhase 3Hackensack
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Phase 1/2Hackensack
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple MyelomaPhase 1Hackensack
CT-95 in Advanced Cancers Associated With Mesothelin ExpressionPhase 1Hackensack
Cardiogenic Shock Working Group Registry—Hackensack
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaPhase 1Hackensack
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaPhase 3Hackensack
Clinical Trial of Approaches to Prostate Cancer SurgeryN/AHackensack
Combination Therapy for the Treatment of Diffuse Midline GliomasPhase 2Hackensack
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage MelanomaPhase 3Hackensack
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialPhase 3Hackensack
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerPhase 3Hackensack
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed MedulloblastomaPhase 2Hackensack
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaPhase 3Hackensack
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/AHackensack
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaPhase 3Hackensack
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes—Hackensack
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)—Hackensack
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Hackensack
Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseasePhase 3Hackensack
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/AHackensack
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasPhase 1/2Hackensack
Embryonal Tumor With Multilayered RosettesPhase 2Hackensack
Empathic Communication Skills (ECS) TrainingN/AHackensack
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T TherapyPhase 2Hackensack
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete RemissionPhase 2Hackensack
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCPhase 2/3Hackensack
Fabry Disease Registry & Pregnancy Sub-registry—Hackensack
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/2Hackensack
First in Human, Dose Escalation Study of AN4005Phase 1Hackensack
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesPhase 2Hackensack
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)Phase 1/2Hackensack
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment—Hackensack
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome—Hackensack
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryN/AHackensack
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyPhase 3Hackensack
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaPhase 2Hackensack
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)Phase 1/2Hackensack
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)—Hackensack
Left vs Left Randomized Clinical TrialN/AHackensack
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies—Hackensack
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)Phase 3Hackensack
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyPhase 2Hackensack
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum DepressionN/AHackensack
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—Hackensack
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)Phase 2Hackensack
Pancreatic Cancer Early Detection Consortium—Hackensack
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)—Hackensack
Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPhase 2Hackensack
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]Phase 3Hackensack
Pembrolizumab and Lenvatinib in Advanced Cervical CancerPhase 2Hackensack
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsPhase 1Hackensack
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCPhase 2Hackensack
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerPhase 3Hackensack
Phase IB/II of CPX-351 for Relapse Prevention in AMLPhase 1/2Hackensack
Pivotal Study for the Cardiac Performance System (CPS)—Hackensack
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell CarcinomaPhase 2/3Hackensack
Post-operative Urinary Retention (POUR) Following Thoracic SurgeryPhase 1/2Hackensack
Project: Every Child for Younger Patients With Cancer—Hackensack
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's DiseaseN/AHackensack
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerPhase 1/2Hackensack
RAPA-201 Therapy of Solid TumorsPhase 1/2Hackensack
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPhase 1Hackensack
Selinexor and Backbone Treatments of Multiple Myeloma PatientsPhase 1/2Hackensack
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsPhase 1/2Hackensack
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesPhase 3Hackensack
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaPhase 3Hackensack
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerPhase 3Hackensack
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsPhase 1Hackensack
Study of AZD0754 in Participants With Metastatic Prostate CancerPhase 1/2Hackensack
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsPhase 1Hackensack
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Phase 3Hackensack
Study of Olverembatinib (HQP1351) in Patients With CML-CPPhase 3Hackensack
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)Phase 1/2Hackensack
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaPhase 1/2Hackensack
Study of SGR-1505 in Mature B-Cell NeoplasmsPhase 1Hackensack
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaPhase 1Hackensack
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIPhase 2Hackensack
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsPhase 1/2Hackensack
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid TumorsPhase 1/2Hackensack
Support for Cancer Patients Awaiting NewsN/AHackensack
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersPhase 1/2Hackensack
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) EpendymomaPhase 2Hackensack
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialPhase 2Hackensack
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck CancerPhase 2Hackensack
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Phase 3Hackensack
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerPhase 2/3Hackensack
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaPhase 2Hackensack
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLPhase 2Hackensack
The Fourth Left Atrial Appendage Occlusion StudyN/AHackensack
The HEARTFELT StudyN/AHackensack
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyPhase 1/2Hackensack
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyPhase 2Hackensack
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaPhase 3Hackensack
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesPhase 1Hackensack
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)Phase 1Hackensack
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 2Hackensack
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisPhase 3Hackensack
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/AHackensack
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With CancerPhase 3Hackensack
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentN/AHackensack
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Phase 3Hackensack
XTX301 in Patients With Advanced Solid TumorsPhase 1/2Hackensack
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors—Hackettstown
ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3Phase 3Haddon Heights
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Haddon Heights
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 3Hamilton
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy DeliveryPhase 2Hamilton
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone MetasPhase 2Hamilton
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDPhase 2Hamilton
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)Phase 2Hamilton
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 3Irvington
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHPhase 3Jackson
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASHPhase 3Jersey City
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)N/AJersey City
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 DiabetesPhase 3Jersey City
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusPhase 3Jersey City
IVUS CHIP UPP Registry—Jersey City
Innovations in Genicular Outcomes Registry—Jersey City
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPhase 2Jersey City
SuperSaturated Oxygen Comprehensive Observational Registry—Jersey City
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)Phase 2Jersey City
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3Lawrence
Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia—Lawrenceville
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerPhase 3Livingston
A Study of Orelabrutinib in Patients With Primary Progressive Multiple SclerosisPhase 3Livingston
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaPhase 3Livingston
Investigating Targetable Metabolic Pathways Sustaining Pancreatic CancerN/ALivingston
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaPhase 3Livingston
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaN/ALivingston
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2Livingston
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentPhase 1/2Livingston
mHealth Mindfulness With Patients With Serious Illness and Their CaregiversN/ALivingston
Vitaccess Real MG Registry—Lumberton
A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung CancerPhase 2Manahawkin
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseasePhase 2Marlboro
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Phase 2Marlton
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)Phase 1Marlton
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderPhase 3Marlton
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)Phase 2Marlton
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2Marlton
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant ResponsePhase 2Marlton
Double-blind, Placebo-controlled Study in Adults With Major Depressive DisorderPhase 2Marlton
Propensity-Matched Study of Cardiac Contractility Modulation Therapy in Heart Failure—Marlton
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to HealPhase 3Marlton
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationPhase 3Mickleton
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Phase 3Middletown
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma—Middletown
A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerN/AMiddletown
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL AmyloidosisPhase 3Middletown
Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialPhase 2Middletown
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry—Millburn
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Phase 3Millville
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 2Millville
Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need CommunitiesN/AMontclair
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During SurgeryPhase 1/2Montvale
Characterization of Hyperpolarized Pyruvate MRI ReproducibilityN/AMontvale
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Phase 2/3Moorestown
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Phase 2Moorestown
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 3Moorestown
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Phase 2Moorestown
The Radiation Oncology Registry and Biosample Repository—Moorestown
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)Phase 3Morristown
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)Phase 2Morristown
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)Phase 3Morristown
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsPhase 1Morristown
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyPhase 2Morristown
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Phase 1/2Morristown
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerPhase 1Morristown
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsPhase 1/2Morristown
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 3Morristown
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)Phase 3Morristown
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).Phase 3Morristown
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Phase 2/3Morristown
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)Phase 3Morristown
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Phase 3Morristown
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsPhase 1Morristown
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerPhase 3Morristown
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatiguePhase 2/3Morristown
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerPhase 3Morristown
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesN/AMorristown
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/AMorristown
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 2Morristown
ATLAS (AltaValve) Pivotal TrialN/AMorristown
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity—Morristown
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry—Morristown
DOC1021 Dendritic Cell Immunotherapy for Refractory MelanomaPhase 1/2Morristown
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsPhase 1/2Morristown
Early Feasibility Study - Edwards APTURE Transcatheter Shunt SystemN/AMorristown
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 2Morristown
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerPhase 3Morristown
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsN/AMorristown
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsPhase 1/2Morristown
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AMLPhase 2/3Morristown
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Phase 3Morristown
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/AMorristown
Pancreatic Cancer Detection Consortium—Morristown
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid TumorsPhase 1Morristown
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Phase 2Morristown
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung CancerPhase 2Morristown
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR—Morristown
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3Morristown
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous MelanomaPhase 3Morristown
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AMorristown
Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisPhase 4Morristown
Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsPhase 2Morristown
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)Phase 3Morristown
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsPhase 1/2Morristown
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 MutationPhase 3Morristown
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLPhase 1/2Morristown
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerPhase 3Morristown
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerPhase 2/3Morristown
TVMR With the INNOVALVE System Trial - Early Feasibility StudyN/AMorristown
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/AMorristown
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 3Morristown
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenN/AMorristown
Prospective Study to Assess a Diagnostic Aid for Cancer—Mountain Lakes
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerPhase 3Mullica Hill
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Phase 3Mullica Hill
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—Mullica Hill
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerPhase 2Mullica Hill
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring HospitalizationPhase 4Mullica Hill
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions—Multiple Locations
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/ANeptune City
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With RavulizumabPhase 4Neptune City
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3Neptune City
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CarePhase 3Neptune City
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPhase 3Neptune City
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)Phase 3Neptune City
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Neptune City
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)Phase 2New Brunswick
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)Phase 1/2New Brunswick
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)Phase 1New Brunswick
A Mobile Health Intervention Among HispanicsN/ANew Brunswick
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsPhase 1New Brunswick
A Phase 1/1b Study of IAM1363 in HER2 CancersPhase 1New Brunswick
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerPhase 3New Brunswick
A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.N/ANew Brunswick
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerPhase 2New Brunswick
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Phase 1New Brunswick
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerPhase 1New Brunswick
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerPhase 1/2New Brunswick
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerPhase 3New Brunswick
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)Phase 1New Brunswick
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Phase 1/2New Brunswick
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Phase 2New Brunswick
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )Phase 1New Brunswick
A Study of Methylprednisolone in People Having Liver SurgeryPhase 3New Brunswick
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase 1New Brunswick
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)Phase 3New Brunswick
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)Phase 1/2New Brunswick
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsPhase 1/2New Brunswick
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1/2New Brunswick
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBCPhase 2New Brunswick
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing LossPhase 3New Brunswick
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1New Brunswick
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaPhase 2New Brunswick
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaPhase 3New Brunswick
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaPhase 3New Brunswick
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerPhase 3New Brunswick
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerPhase 1/2New Brunswick
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsPhase 1New Brunswick
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 2New Brunswick
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerPhase 3New Brunswick
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerPhase 2New Brunswick
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerPhase 1/2New Brunswick
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—New Brunswick
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received TreatmentPhase 1/2New Brunswick
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer ScreeningN/ANew Brunswick
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older AdultsPhase 2New Brunswick
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3New Brunswick
Abbott Structural Heart Device Registry—New Brunswick
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3New Brunswick
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial CancerN/ANew Brunswick
Addressing Genomic Disparities in Cancer SurvivorsN/ANew Brunswick
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmPhase 2New Brunswick
Bright Ideas - CIN Feasibility StudyN/ANew Brunswick
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.Phase 2New Brunswick
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy—New Brunswick
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting—New Brunswick
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyPhase 3New Brunswick
Developing and Implementing HPV SCREENEDN/ANew Brunswick
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersPhase 1/2New Brunswick
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersPhase 2New Brunswick
Effects of Latin Dancing on Sleep Quality in Hispanic Cancer SurvivorsN/ANew Brunswick
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsPhase 3New Brunswick
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic PatientsN/ANew Brunswick
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical GastrojejunostomyN/ANew Brunswick
Exercise and Intranasal Insulin in Type 2 DiabetesPhase 2/3New Brunswick
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy—New Brunswick
Extracellular Vesicles, Insulin Action, and ExerciseN/ANew Brunswick
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerPhase 1New Brunswick
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPhase 2New Brunswick
Individualizing Treatment for Asthma in Primary Care (Full Study)Phase 4New Brunswick
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerN/ANew Brunswick
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerPhase 1New Brunswick
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsPhase 1New Brunswick
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïvePhase 1/2New Brunswick
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular LymphomaPhase 2New Brunswick
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell MobilizationEarly 1New Brunswick
Luminal Bladder Cancer Effective Response to Neoadjuvant Chemotherapy (LUMBER-NAC)Phase 2New Brunswick
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial—New Brunswick
Metabolic Health, Bones and Nuts During Weight Loss in AdultsN/ANew Brunswick
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer SurvivorsN/ANew Brunswick
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone LymphomaPhase 2New Brunswick
MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsN/ANew Brunswick
Naltrexone and Propranolol Combined With ImmunotherapyPhase 1New Brunswick
Parkinson's Foundation PD GENEration Genetic Registry—New Brunswick
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionPhase 1New Brunswick
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2New Brunswick
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3New Brunswick
Project CARE: CAncer Risk EvaluationN/ANew Brunswick
Reducing Urban Cervical Cancer DisparitiesN/ANew Brunswick
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerPhase 2New Brunswick
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Phase 3New Brunswick
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—New Brunswick
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive DiseasePhase 2New Brunswick
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid MalignanciesPhase 1/2New Brunswick
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid TumorsPhase 1/2New Brunswick
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial CarcinomaPhase 2New Brunswick
SilverCloud as a School-Based Intervention for Vulnerable YouthN/ANew Brunswick
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)N/ANew Brunswick
Spine Oncology Registry—New Brunswick
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLPhase 3New Brunswick
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaPhase 1/2New Brunswick
Study of APR-1051 in Patients With Advanced Solid TumorsPhase 1New Brunswick
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 2New Brunswick
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaPhase 3New Brunswick
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)Phase 3New Brunswick
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerPhase 1New Brunswick
Study of GS-5319 Given Alone or in Combination in Adults With Solid TumorsPhase 1New Brunswick
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1New Brunswick
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)Phase 3New Brunswick
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)Phase 1/2New Brunswick
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerPhase 2New Brunswick
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPhase 1New Brunswick
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaPhase 1New Brunswick
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPPhase 2New Brunswick
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisPhase 3New Brunswick
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Phase 1/2New Brunswick
Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their ParentsN/ANew Brunswick
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLPhase 2New Brunswick
SynKIR-310 for Relapsed/Refractory B-NHLPhase 1New Brunswick
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsN/ANew Brunswick
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Phase 3New Brunswick
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaPhase 3New Brunswick
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1New Brunswick
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerPhase 2New Brunswick
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerPhase 1New Brunswick
The Ailliance Post-Market Clinical StudyN/ANew Brunswick
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal CancerN/ANew Brunswick
The Salt Study for Heart FailureN/ANew Brunswick
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaPhase 2New Brunswick
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)N/ANew Brunswick
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin TherapyN/ANew Brunswick
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto—New Brunswick
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus ErythematosusPhase 3Newark
Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseasePhase 1/2Newark
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3Newark
Exercise to Improve Brain Health in Older African AmericansPhase 2Newark
Gait Adaptation StudyEarly 1Newark
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ANewark
Liver Transplantation in Intrahepatic Cholangiocarcinoma—Newark
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 3Newark
PARTNER 3 Trial - Aortic Valve-in-ValveN/ANewark
Reducing Risk for Infective EndocarditisN/ANewark
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersN/ANewark
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 3Northfield
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentPhase 3Northfield
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease—Nutley
A Postmarketing Study of Lecanemab for the Treatment of Participants With Alzheimer's Disease—Nutley
Mosaic Trial for Stem Cell Transplant RecipientsN/ANutley
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3Oradell
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot UlcersPhase 1/2Oradell
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerPhase 3Paramus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPhase 3Paramus
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Phase 2Paramus
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerPhase 2/3Paramus
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3Paramus
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)Phase 3Paramus
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral NeuropathyPhase 3Paramus
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic CancerPhase 1Paramus
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibPhase 1/2Paramus
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA—Paramus
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Phase 3Paramus
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)Phase 2Paramus
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePhase 2Pennington
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerPhase 3Pennington
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerPhase 4Pennington
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/APennington
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesPhase 1Piscataway
Rutgers University Study of the Genetics of Blood Cancers—Piscataway
Rutgers University Study of the Genetics of Breast Cancer.—Piscataway
Rutgers University Study of the Genetics of Pulmonary Hypertension—Piscataway
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical TrialsN/APlainsboro
Foundational Programs to Combat Clinician StressN/APlainsboro
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer—Plainsboro
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/APomona
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsN/APomona
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 3Princeton
Brexanolone Lifting Outcomes Of MomsPhase 3Princeton
Phase 1 Study of CLR 125 in Triple Negative Breast CancerPhase 1Princeton
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid TumorsPhase 1Princeton
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsPhase 1/2Princeton
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderPhase 2Princeton
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)Phase 3Ridgewood
His-Bundle Corrective Pacing in Heart FailureN/ARidgewood
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3Ridgewood
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPhase 2Saddle Brook
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice—Sewell
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Phase 3Sewell
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERPhase 2Sewell
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational DiabetesN/ASewell
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsN/ASewell
Neurocognition in Patients With Multiple Brain Metastases Treated With RadiosurgeryN/ASewell
Renal Denervation + PVI vs PVI Alone for Persistent AFN/AShort Hills
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionPhase 3Short Hills
Safety and Effectiveness of the HIT Reverse HRSN/ASomers Point
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusPhase 3Somerset
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy—Somerset
Registry Study for Radiation Therapy Outcomes—Somerset
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 2Sparta
Caris Biorepository Research Protocol—Sparta
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Phase 3Springfield
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseasePhase 2Springfield
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic CancerPhase 1/2Summit
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2Summit
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)Phase 1/2Summit
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerPhase 3Summit
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2Summit
Collection of Sputum and Labeling for Lung Cancer—Summit
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerPhase 3Summit
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesPhase 2Teaneck
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Phase 3Teaneck
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyPhase 2Teaneck
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 3Teaneck
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerPhase 3Teaneck
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 3Teaneck
A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderPhase 2Toms River
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's DiseasePhase 1Toms River
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's DiseasePhase 3Toms River
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 3Toms River
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3Toms River
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's DementiaPhase 2Toms River
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's DiseasePhase 2Toms River
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 3Toms River
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseasePhase 3Toms River
ALTO-100 in Bipolar Disorder With Depression (BD-D)Phase 2Toms River
ALTO-207 in Adults With Treatment-resistant Depression (TRD)Phase 2Toms River
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3Toms River
Open-label Extension Study in Participants With Early Alzheimer's DiseasePhase 2Toms River
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderPhase 2Toms River
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 2Toms River
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPhase 3Toms River
The Use of AR / VR in Patients Presenting to the ED With Renal ColicN/AToms River
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management—Totowa
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs—Totowa
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisPhase 3Totowa
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)Phase 3Trenton
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe AsthmaPhase 3Union City
Reaching Rural Cancer Survivors Who Smoke Using Text-Based ProgramPhase 3Vineland
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 3Voorhees Township
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerPhase 3Voorhees Township
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyN/AVoorhees Township
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyPhase 2/3Voorhees Township
PROton Therapy for Post Surgical Treatment of GYNecologic CancerPhase 2Voorhees Township
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyN/AVoorhees Township
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsPhase 3Voorhees Township
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast CancerPhase 2Voorhees Township
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.N/AVoorhees Township
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenPhase 3Voorhees Township
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 3Warren Township
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityPhase 3Warren Township
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisPhase 3Warren Township
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisPhase 3Warren Township
LRG GIST Patient Registry—Wayne
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants—West Long Branch
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 2West Long Branch
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 2West Long Branch
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusPhase 3West Long Branch
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 1West Long Branch
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisPhase 4West Long Branch
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPhase 3West New York
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MSN/AWest Orange
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPhase 3Westwood
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersN/AWestwood
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide—Whippany
Transcranial Direct Current Stimulation for DepressionN/AWoodbridge

Frequently Asked Questions

How many clinical trials are recruiting in New Jersey?

There are currently 1,142 actively recruiting clinical trials in New Jersey across 113 cities.

Which cities in New Jersey have the most clinical trials?

The top cities are Basking Ridge (294 trials), Middletown (294 trials), Montvale (290 trials).

What conditions are being studied in New Jersey?

Researchers in New Jersey are studying Alzheimer's Disease, Anxiety, Arthritis, Asthma, Breast Cancer, and 12 more conditions.

What trial phases are available in New Jersey?

Available phases include Phase 3 (25%), Phase 2 (24%), NA (13%).

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.